New 2025 catalogue — full Derma Shape line refresh
Updated formulas for all 8 products, improved packaging and expanded scientific protocols.
Read more
Full-cycle research on polydeoxyribonucleotide technology in skin regeneration.
Our partner laboratories in France have completed a full-cycle clinical study of the Derma Shape PDRN 9% formulation, the highest concentration of polydeoxyribonucleotides available on the professional market.
The protocol combined in-vitro assays on human dermal fibroblasts with a 12-week clinical evaluation on a cohort of adult volunteers. Biopsy analysis confirmed a measurable increase in fibroblast activity and collagen synthesis, and clinical scoring by independent dermatologists showed improvement in skin density, elasticity and post-procedure recovery time.
The full study dossier is being prepared for publication in peer-reviewed aesthetic medicine journals and will be made available to certified Derma Shape partner clinics as part of the 2025 training programme.